Home/Eterna Therapeutics/Joshua Leonard

JL

Joshua Leonard

Chief Financial Officer

Eterna Therapeutics

Therapeutic Areas

Regenerative Medicine Oncology Autoimmune Disorders

Eterna Therapeutics Pipeline

Drug	Indication	Phase
Hypoimmune Engineered Cells	Regenerative Medicine (e.g., Type 1 Diabetes)	Preclinical
mRNA-reprogrammed T Cells	Oncology (CAR-T/TCR-T therapies)	Preclinical
In Vivo Cell Reprogramming	Autoimmune Disorders, Tissue Repair	Discovery

Leadership Team at Eterna Therapeutics

Interim President and Chief Executive Officer

Former President and Chief Executive Officer

View full Eterna Therapeutics profile